Hepion Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 25 shareholders own 9.87% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
4.34%	The Vanguard Group, Inc.	165,509	€1.1m	0%	no data
2.1%	BlackRock, Inc.	80,138	€556.1k	0.33%	no data
0.86%	Geode Capital Management, LLC	32,822	€227.8k	0%	no data
0.83%	Charles Schwab Investment Management, Inc.	31,535	€218.8k	1,900%	no data
0.41%	State Street Global Advisors, Inc.	15,675	€108.8k	0%	no data
0.37%	Renaissance Technologies LLC	14,215	€98.6k	15.8%	no data
0.2%	Susquehanna International Group, LLP, Asset Management Arm	7,737	€53.7k	61.3%	no data
0.17%	Northern Trust Global Investments	6,602	€45.8k	0%	no data
0.12%	Morgan Stanley & Co. International Plc Investment Account	4,410	€30.6k	9.7%	no data
0.075%	PNC Financial Services Group Inc., Banking Investments	2,876	€20.0k	-0.07%	no data
0.062%	Robert Foster	2,364	€16.4k	0%	no data
0.059%	Vision2020 Wealth Management Corp.	2,263	€15.7k	44%	no data
0.039%	Petrus L. Wijngaard	1,501	€10.4k	0%	no data
0.034%	Two Sigma Advisers, LP	1,295	€9.0k	0%	no data
0.028%	Gesiuris, SA	1,067	€7.4k	0%	no data
0.026%	Cetera Investment Advisers LLC	987	€6.9k	-33.6%	no data
0.02%	John Cavan	747	€5.2k	0%	no data
0.018%	UBS Asset Management AG	703	€4.9k	0%	no data
0.017%	Amussen, Hunsaker & Associates, LLC	665	€4.6k	0%	no data
0.017%	Group One Trading LP, Asset Management Arm	656	€4.6k	-46%	no data
0.016%	Gary Jacob	610	€4.2k	0%	no data
0.015%	Lord, Abbett & Co. LLC	578	€4.0k	0%	no data
0.014%	Tower Research Capital LLC	528	€3.7k	-67.3%	no data
0.011%	Victory Capital Management Inc.	426	€3.0k	0%	no data
0.0092%	John Brancaccio	352	€2.4k	0%	no data